A data tool that could potentially aid the prediction of how glaucoma progresses is currently in development. The aim of the tool is to improve personalised care for patients.
The Moorfields Glaucoma BioResource, which has been funded by both Fight for Sight and Glaucoma UK, addressed the need to improve management of the disease by linking genetic and clinical data.
A team of researchers hoped to develop prediction models to identify primary open-angle glaucoma patients at the highest risk of progression and blindness.
Ophthalmologist, Dr Anthony Khawaja, said: ‘There is an urgent need to improve care for glaucoma patients. The potential of a prediction model could be huge. We foresee the Glaucoma Bioresource will be a powerful enabler of translation to clinical benefit of multiple streams of genetics research. We eagerly await the outcomes of the project,’
